ZELIRA Therapeutics is a global biopharmaceutical company developing and marketing clinically validated cannabinoid-based medicines targeting insomnia and autism.

ZELIRA is committed to becoming the trusted partner for delivery of clinically validated cannabinoid medicines.   Our mission is for healthcare professionals to prescribe our medicines with the same confidence they would other pharmaceuticals.